Dr. Devon Chabot-Richards, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $352.94 | 16 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $159.19 | 12 | $0 (2020) |
| Blueprint Medicines Corporation | $122.85 | 1 | $0 (2024) |
| Promega Corporation | $70.90 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $145.47 | 2 | Blueprint Medicines Corporation ($122.85) |
| 2023 | $30.50 | 1 | Promega Corporation ($30.50) |
| 2022 | $17.78 | 1 | Promega Corporation ($17.78) |
| 2020 | $15.36 | 1 | Celgene Corporation ($15.36) |
| 2019 | $68.07 | 5 | Celgene Corporation ($68.07) |
| 2018 | $41.13 | 3 | Celgene Corporation ($41.13) |
| 2017 | $34.63 | 3 | Celgene Corporation ($34.63) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/27/2024 | Blueprint Medicines Corporation | — | Food and Beverage | In-kind items and services | $122.85 | General |
| 04/19/2024 | Promega Corporation | ONCOMATE MSI DX ANALYSIS SYSTEM (Device) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Oncology | ||||||
| 04/27/2023 | Promega Corporation | ONCOMATE MSI DX ANALYSIS SYSTEM (Device) | Food and Beverage | In-kind items and services | $30.50 | General |
| Category: Oncology | ||||||
| 03/02/2022 | Promega Corporation | ONCOMATE MSI DX ANALYSIS SYSTEM (Device) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Oncology | ||||||
| 02/21/2020 | Celgene Corporation | Pomalyst (Drug), Revlimid | Food and Beverage | Cash or cash equivalent | $15.36 | General |
| Category: Hematology | ||||||
| 11/22/2019 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Hematology / Oncology | ||||||
| 10/25/2019 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: Hematology / Oncology | ||||||
| 08/26/2019 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: Hematology / Oncology | ||||||
| 04/26/2019 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Hematology / Oncology | ||||||
| 02/22/2019 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Hematology / Oncology | ||||||
| 11/30/2018 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Hematology / Oncology | ||||||
| 08/24/2018 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Hematology / Oncology | ||||||
| 02/23/2018 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Hematology / Oncology | ||||||
| 10/27/2017 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: Hematology / Oncology | ||||||
| 04/21/2017 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: Hematology / Oncology | ||||||
| 02/24/2017 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: Hematology / Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 50 | 57 | $7,136 | $2,079 |
| 2022 | 2 | 65 | 68 | $7,321 | $2,080 |
| 2021 | 3 | 93 | 103 | $8,547 | $2,314 |
| 2020 | 6 | 147 | 167 | $11,138 | $3,087 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0452 | Molecular pathology procedure; physician interpretation and report | Facility | 2023 | 50 | 57 | $7,136 | $2,079 | 29.1% |
| G0452 | Molecular pathology procedure; physician interpretation and report | Facility | 2022 | 46 | 49 | $6,125 | $1,714 | 28.0% |
| 85060 | Blood smear interpretation by physician with written report | Facility | 2022 | 19 | 19 | $1,196 | $365.81 | 30.6% |
| G0452 | Molecular pathology procedure; physician interpretation and report | Facility | 2021 | 40 | 45 | $5,121 | $1,369 | 26.7% |
| 84165 | Protein measurement, serum | Facility | 2021 | 35 | 38 | $2,066 | $554.42 | 26.8% |
| 85060 | Blood smear interpretation by physician with written report | Facility | 2021 | 18 | 20 | $1,360 | $390.40 | 28.7% |
| G0452 | Molecular pathology procedure; physician interpretation and report | Facility | 2020 | 43 | 50 | $2,444 | $728.65 | 29.8% |
| 84165 | Protein measurement, serum | Facility | 2020 | 38 | 41 | $2,375 | $596.31 | 25.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2020 | 11 | 18 | $1,890 | $556.89 | 29.5% |
| 85060 | Blood smear interpretation by physician with written report | Facility | 2020 | 25 | 27 | $1,809 | $517.38 | 28.6% |
| 88108 | Cell examination of specimen | Facility | 2020 | 19 | 20 | $1,349 | $369.58 | 27.4% |
| 88342 | Tissue or cell analysis by immunologic technique | Facility | 2020 | 11 | 11 | $1,271 | $317.75 | 25.0% |
About Dr. Devon Chabot-Richards, M.D
Dr. Devon Chabot-Richards, M.D is a Anatomic Pathology & Clinical Pathology healthcare provider based in Albuquerque, New Mexico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2007. The National Provider Identifier (NPI) number assigned to this provider is 1366648404.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Devon Chabot-Richards, M.D has received a total of $352.94 in payments from pharmaceutical and medical device companies, with $145.47 received in 2024. These payments were reported across 16 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($352.94).
As a Medicare-enrolled provider, Chabot-Richards has provided services to 355 Medicare beneficiaries, totaling 395 services with total Medicare billing of $9,559. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology & Clinical Pathology
- Location Albuquerque, NM
- Active Since 06/25/2007
- Last Updated 01/24/2025
- Taxonomy Code 207ZP0102X
- Entity Type Individual
- NPI Number 1366648404
Products in Payments
- Revlimid (Drug) $143.83
- ONCOMATE MSI DX ANALYSIS SYSTEM (Device) $70.90
- Pomalyst (Drug) $15.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology & Clinical Pathology Doctors in Albuquerque
Michael Crossey, Md/Phd, MD/PHD
Anatomic Pathology & Clinical Pathology — Payments: $35,536
Dr. Joseph Griggs, D.o, D.O
Anatomic Pathology & Clinical Pathology — Payments: $29,558
Douglas Clark, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $13,838
Richard Feddersen, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $4,885
Dr. Madeline Woodward, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $3,530
Dr. Evelyn Lockhart, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $3,300